XML 33 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Common Stock (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Summary of Common Stock

The following table summarizes the cumulative total shares issued, net proceeds received, and weighted average offering price in public offerings of the Company’s common stock since the IPO in June 2011, except for the issuances under the ATM Program as described further below.

 

Period

 

Cumulative Number of Shares

 

 

Cumulative Gross Proceeds

 

 

Cumulative Underwriting Fees and Commissions and Offering Costs (1)

 

 

Weighted Average Offering Price

 

Cumulative since IPO

 

 

14,388,414

 

 

$

236,597

 

 

$

8,989

 

 

$

16.44

 

 

(1) Fidus Investment Advisors, LLC agreed to bear a cumulative of $1,925 of underwriting fees and commissions and offering costs associated with these offerings (such amounts are not included in the number reported above). All such payments made by Fidus Investment Advisors, LLC are not subject to reimbursement by the Company.

Summary of Equity ATM Program The gross proceeds raised, the related sales agent commissions and the offering expenses, the net proceeds raised, and the average price at which shares were issued under the ATM Program for the three months ended March 31, 2024 and 2023 are as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

Underwriting

 

 

 

 

 

 

Number of

 

 

Offering

 

 

Gross

 

 

Fees and

 

 

Net

 

 

 

Shares

 

 

Price

 

 

Proceeds

 

 

Commissions

 

 

Proceeds

 

Three Months Ended March 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

January 1, 2023 through March 31, 2023

 

 

260,610

 

 

$

20.68

 

 

$

5,389

 

 

$

81

 

 

$

5,308

 

Total

 

 

260,610

 

 

$

20.68

 

 

$

5,389

 

 

$

81

 

 

$

5,308

 

Three Months Ended March 31, 2024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

January 1, 2024 through March 31, 2024

 

 

987,170

 

 

$

19.66

 

 

$

19,408

 

 

$

228

 

 

$

19,180

 

Total

 

 

987,170

 

 

$

19.66

 

 

$

19,408

 

 

$

228

 

 

$

19,180

 

(1) Net proceeds exclude amortization of deferred equity financing costs.